Target intelligence / Profile preview

Immunoglobulin kappa variable 1D-12 (IGKV1D-12)

Target
IGKV1D-12
Molecular classification
Immunoglobulin variable region, Antibody gene segment, Other
01

Overview

The Immunoglobulin kappa variable 1D-12 gene (IGKV1D-12) encodes part of the variable region of the immunoglobulin kappa light chain, which, together with complementary regions from heavy chains, forms the antigen-binding domain of B-cell receptors and secreted antibodies. This region is assembled into mature immunoglobulins through the process of V-(D)-J recombination and is subject to somatic hypermutation to increase antigen affinity during immune responses. IGKV1D-12 is located within the distal cluster of the IGK locus on chromosome 2p11.2, and its protein product appears in both membrane-bound and secreted immunoglobulins, facilitating antigen recognition and humoral immunity[1][3][4]. This gene segment is one of many that contribute to the immense diversity of the human antibody repertoire.

Other names
IGKV1D-12IGKV1D12L19Immunoglobulin kappa chain V-I region WesIg kappa chain V-I region Wes
02

Biological functions

Antigen bindingGeneration of antibody diversity via V-(D)-J rearrangement and somatic hypermutationImmune response
03

Disease associations

Genetic rearrangements or variants in immunoglobulin regions may contribute to immune disorders, autoimmunity, lymphoid malignancies, but IGKV1D-12 is not a direct disease driver or therapeutic target

Beyond the preview

Go deeper on Immunoglobulin kappa variable 1D-12 (IGKV1D-12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 1D-12 (IGKV1D-12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call